ClinicalTrials.Veeva

Menu

inflAmmatory maRkers in Blood and Thrombus Aspirated From Patients With acutE myocaRdial Infarction With St-segment elevAtion (ARTERIA)

F

Fundación Canaria Rafael Clavijo para la Investigación Biomédica

Status

Unknown

Conditions

Patients Admitted With the Diagnosis of ST-elevation Acute Coronary Syndrome

Treatments

Other: Biomarkers to analyze both intracoronary thrombi as blood

Study type

Observational

Funder types

Other

Identifiers

NCT01757886
ARTERIA-2012 (Other Identifier)

Details and patient eligibility

About

The prognostic value of inflammatory markers in acute coronary syndrome has been extensively demonstrated, however it is still unknown whether there is an association between circulating and local (thrombus) inflammatory molecules, and the subset of molecules that provide better prognostic information in patients with ST-elevation acute coronary syndrome.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • They include patients of both sexes, without limits of age, with a diagnosis of STEMI within 12 hours after the beginning of symptoms. ST-elevation myocardial infarction was defined in the presence of symptoms consistent, persistent elevation (> 20 min) ST segment ≥ 1 mm in at least two contiguous leads or in the presence of left bundle branch block presumably new onset and cardiac troponin I elevation

Exclusion criteria

  • Injury significant common core of left coronary artery (stenosis greater than or equal to 50% of the vessel lumen).
  • Pre-Fibrinolysis percutaneous coronary intervention.
  • Previous coronary bypass surgery.
  • Thyrotoxicosis.
  • Having an inflammatory systemic or local inflammatory process.
  • Malignant neoplasm.
  • Any disease that seriously compromise the prognosis and / or systemic inflammatory response generated.
  • No thrombotic material obtained in the thrombus or insufficient for performing biochemical determinations.

Trial design

100 participants in 1 patient group

ST-elevation acute coronary syndrome
Description:
ARTERY is a prospective, multicenter, which will include patients admitted with the diagnosis of ST-elevation acute coronary syndrome and thrombus aspiration is performed during primary angioplasty
Treatment:
Other: Biomarkers to analyze both intracoronary thrombi as blood

Trial contacts and locations

2

Loading...

Central trial contact

Alberto Dominguez-Rodriguez, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems